Superfund Research Program
Nuclear Receptor Mediated Epigenetic and Immune Cell Changes in Liver Fibrosis Resulting From Toxicant Exposure
Project Leader: Ronald M. Evans (Salk Institute for Biological Studies)
Co-Investigator: Michael Downes (Salk Institute for Biological Studies)
Grant Number: P42ES010337
Funding Period: 2017-2023
Project-Specific Links
- Project Summary
Grant Recipient Patent List
Patents
- Chimeric Fibroblast Growth Factor (Fgf) 2/Fgf1 Peptides And Methods Of Use
Number: 9,925,243
Year: 2018
Patent Status: Issued
Authors: Atkins, A.R., M. Downes, R.M. Evans, J. Suh, W. Kwiatkowski, S. Choe - FGF2 Truncations and Methods of Use Thereof
Number: 15/617,81
Year: 2017
Patent Status: Pending
Authors: Atkins, A.R., M. Downes, R.M. Evans, R.T. Yu, J. Suh - Increasing Storage of Vitamin A, Vitamin D, and/or Lipids
Number: 15/984,146
Year: 2018
Patent Status: Pending
Authors: Ding, N., M. Downes, R.M. Evans, M.H. Sherman - Mutated Fibroblast Growth Factor (FGF) 1 and Methods of Use
Number: 9,925,241
Year: 2018
Patent Status: Issued
Authors: Atkins, A.R., M. Downes, R.M. Evans, J. Suh - Mutated Fibroblast Growth Factor (FGF) 1 and Methods of Use
Number: 15/910,332
Year: 2018
Patent Status: Pending
Authors: Atkins, A.R., M. Downes, R.M. Evans, J. Suh